USA. FDA Approves First Nalmefene Auto-Injector for Opioid Overdose

The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people aged 12 years or older. (Medscape, USA, 08.08.2024)